A Study of OPD5 Followed by Autologous Stem Cell Transplant for Patients With Relapsed Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- Status
- RECRUITING
- Phase
- NA
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Selinexor in Combination With Thalidomide and Dexamethasone in RRMM
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Methods of T Cell Depletion Trial (MoTD)
- Status
- RECRUITING
- Phase
- PHASE2
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
- Status
- RECRUITING
- Phase
- N/A
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
- Status
- TERMINATED
- Phase
- PHASE1
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ATG-010(Selinexor) in Combination With Chemotherapy in RRMM
- Status
- RECRUITING
- Phase
- PHASE2
Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression
- Status
- COMPLETED
- Phase
- NA
Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients
- Status
- COMPLETED
- Phase
- NA
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- N/A
Double Filtration Plasmapheresis Combined With Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE1
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2